1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
    Journal Article

    Rugo, H. S.; Bardia, A.; Marmé, F.; Cortes, J.; Schmid, P.; Loirat, D.; Trédan, O.; Ciruelos, E.; Dalenc, F.; Pardo, P. G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
    Journal Article

    Rosenbaum, E.; Chugh, R.; Ryan, C. W.; Agulnik, M.; Milhem, M. M.; George, S.; Jones, R. L.; Chmielowski, B.; Van Tine, B. A.; Tawbi, H.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • A randomized controlled trial of emotion regulation therapy for cancer caregivers: A mechanism-targeted approach to addressing caregiver distress
    Journal Article

    Applebaum, A. J.; Loschiavo, M.; Morgan, K.; Mennin, D. S.; Fresco, D. M.; Hoyt, M. A.; Schofield, E.; O'Toole, M. S.; Cohn, J.; Jacobs, J. M.
    Contemporary Clinical Trials (2022)

    Fulltext@MSK | Save
  • Transcriptomic correlates of tumor cell PD-L1 expression and response to nivolumab monotherapy in metastatic clear cell renal cell carcinoma
    Journal Article

    Denize, T.; Hou, Y.; Pignon, J. C.; Walton, E.; West, D. J.; Freeman, G. J.; Braun, D. A.; Wu, C. J.; Gupta, S.; Motzer, R. J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Comment on: Hasselgren K, et al. ALPPS improves survival compared with TSH in patients affected of CRLM: Survival analysis from the randomized controlled trial LIGRO. Ann Surg. 2021;273(3):442-448
    Correspondence

    Jarnagin, W. R.; Gönen, M.; D'Angelica, M. I.; Kingham, T. P.; Balachandran, V. P.; Wei, A. C.; Soares, K.; Drebin, J.
    Annals of Surgery (2022)

    Fulltext@MSK | Save
  • Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
    Journal Article

    Jahn, N.; Jahn, E.; Saadati, M.; Bullinger, L.; Larson, R. A.; Ottone, T.; Amadori, S.; Prior, T. W.; Brandwein, J. M.; Appelbaum, F. R.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • Meaning-Centered Psychotherapy for Cancer Caregivers: A pilot trial among caregivers of patients with glioblastoma multiforme
    Journal Article

    Applebaum, A. J.; Baser, R. E.; Roberts, K. E.; Lynch, K.; Gebert, R.; Breitbart, W. S.; Diamond, E. L.
    Translational Behavioral Medicine (2022)

    Fulltext@MSK | Save
  • Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer
    Journal Article

    Barrios, C. H.; Saji, S.; Harbeck, N.; Zhang, H.; Jung, K. H.; Patel, S.; Patel, S.; Duc, A. N.; Liste-Hermoso, M.; Chui, S. Y.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Atezolizumab with neoadjuvant anti-human epidermal growth factor receptor 2 therapy and chemotherapy in human epidermal growth factor receptor 2-positive early breast cancer: Primary results of the randomized phase III IMpassion050 trial
    Journal Article

    Huober, J.; Barrios, C. H.; Niikura, N.; Jarząb, M.; Chang, Y. C.; Huggins-Puhalla, S. L.; Pedrini, J.; Zhukova, L.; Graupner, V.; Eiger, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Acupuncture versus massage for pain in patients living with advanced cancer: A protocol for the IMPACT randomised clinical trial
    Journal Article

    Romero, S. A. D.; Emard, N.; Baser, R. E.; Panageas, K.; MacLeod, J.; Walker, D.; Barton-Burke, M.; Liou, K.; Deng, G.; Farrar, J.; more...
    BMJ Open (2022)

    Fulltext@MSK | Save